Compounded preparations with nystatin for oral and oromucosal administration

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F13%3A10195049" target="_blank" >RIV/00216208:11110/13:10195049 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11160/13:10195049

Result on the web

<a href="http://www.ptfarm.pl/pub/File/Acta_Poloniae/2013/4/759.pdf" target="_blank" >http://www.ptfarm.pl/pub/File/Acta_Poloniae/2013/4/759.pdf</a>

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Compounded preparations with nystatin for oral and oromucosal administration

Original language description

Therapy of oral, esophageal and gastrointestinal candidiasis is still a common problem that can be solved by an administration of antimycotics. Major disadvantage of registered commercial antifungal medicinal products is their price, so the health care system and its payers may profit from extemporaneous compounding. An appropriate drug therapy for candidiasis (trash) is nystatin, which is a substance available in the Czech Republic for the magistral preparation relatively recently, since 2010. Making formulas for extemporaneous compounding is quite simple and preparations particularly useful for dentists, pediatricians, otolaryngolgists, oncologists and gastroenterologists. The authors formulated composition of viscous oromucosal suspension, oral/oromucosal hydrogel and oromucosal gelatine globule which may be present as compounded products containing nystatin for oromucosal and/or oral administration. The preparation is practically verified and magistral products have been already us

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FR - Pharmacology and apothecary chemistry

OECD FORD branch

—

Project

<a href="/en/project/GAP301%2F10%2F0756" target="_blank" >GAP301/10/0756: The role of Plzf (Promyelocytic leukemia zinc finger) gene in the pathogenesis of cardiovascular and metabolic disturbances in rat models</a><br>

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2013

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Acta Poloniae Pharmaceutica

ISSN

0001-6837

e-ISSN

—

Volume of the periodical

70

Issue of the periodical within the volume

4

Country of publishing house

PL - POLAND

Number of pages

4

Pages from-to

759-762

UT code for WoS article

000323858400019

EID of the result in the Scopus database

—